サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1780324

感染症体外診断薬市場規模と予測 2021年～2031年、世界と地域のシェア、動向、成長機会分析レポート：用途、エンドユーザー、地域別

Infectious Disease In vitro Diagnostics Market Size and Forecast 2021-2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Application, End User, and Geography

出版日
ページ情報
英文 190 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.26円
感染症体外診断薬市場規模と予測 2021年～2031年、世界と地域のシェア、動向、成長機会分析レポート：用途、エンドユーザー、地域別
出版日: 2025年07月07日
発行: The Insight Partners
ページ情報: 英文 190 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

感染症体外診断薬市場規模は、2024年の456億9,000万米ドルから2031年には767億1,000万米ドルに成長すると予測されており、2025～2031年のCAGRは7.7%と予測されています。感染症の流行の増加と主要企業による戦略的開拓は、感染症体外診断薬市場規模の拡大に寄与する注目すべき要因です。しかし、不十分な償還シナリオが感染症体外診断薬市場の成長を阻害しています。

分子診断薬と自動化システムの開発と統合を含む技術的進歩は、感染症検出の精度、スピード、アクセシビリティを向上させる。以下はその一例である：

2024年6月、MP Biomedicals社は、ヘリコバクター・ピロリ、サルモネラ菌、コレラ菌の迅速イムノクロマトアッセイの新ラインを発表しました。

2024年6月、ロシュはSARS-CoV-2、インフルエンザA/B、RSVを同時に検出するよう更新されたcobas liat multiplex PCR panelのFDA緊急使用承認（EUA）を取得し、20分未満で症候性呼吸器感染症管理を進める。

2024年7月、シャーロック・バイオサイエンシズは2025年の発売を目指し、2024年5月にCRISPRベースの淋病とクラミジアの一般用（OTC）検査の臨床試験を開始しました。また、AIとナノテクノロジーによる機械学習を統合したAPEX-TBも発売され、携帯機器を用いた正確なリアルタイムの分子診断を提供します。

2024年6月、QIAGENはデジタルPCR（dPCR）プラットフォームQIAcuityに、新たに35種類のウェットラボ試験済みデジタルPCR微生物DNA検出アッセイを導入し、微生物研究における能力を顕著に強化しました。

これらの進歩は、感染症治療の未来を導く、分散型、ユーザー中心、高速診断技術に向けた大きな動きの一部です。このことは、今後数年間における感染症体外診断薬市場の成長に寄与すると予想されます。

エンドユーザー別インサイト

感染症体外診断市場は、エンドユーザー別に病院・診療所、診断研究所、血液銀行、その他に区分されます。2024年の感染症体外診断市場シェアは、病院・診療所が最大でした。ラッサ熱、コレラ、結核、マラリアなどの頻発により、病院・診療所における正確でタイムリーな診断の必要性は着実に高まっています。患者数の急増と質の高い医療への需要により、病院は分子診断法を含むより高度な診断ツールの導入を進めています。政府資金の増加、ドナー支援、二次・三次病院のインフラ整備がIVD製品の採用をさらに後押ししています。病院のプロトコールに体外診断用医薬品を組み込むことで、患者の転帰が改善され、不必要な抗生物質の使用が減り、都市部や農村部の保健所における感染症の管理が確実に改善されるため、感染症体外診断用医薬品市場の成長に拍車がかかります。

世界保健機関（WHO）およびメキシコ保健省国立呼吸器疾患研究所は、感染症体外診断市場レポート作成時に参照した一次情報および二次情報の一つです。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • アナリスト市場の展望

第3章 調査手法

  • 2次調査
  • 1次調査
    • 仮説の策定
    • マクロ経済要因分析
    • ファンデーション数値の開発
    • データの三角測量
    • 国レベルのデータ
  • 仮定と限界

第4章 感染症体外診断薬市場情勢

  • PEST分析

第5章 感染症体外診断薬市場-主要市場力学

  • 感染症体外診断薬市場- 主な市場力学
  • 市場促進要因
    • 感染症罹患率の増加
    • 主な企業による戦略的発展
  • 市場抑制要因
    • 不十分な償還シナリオ
  • 市場機会
    • 感染症に対する認識を高めるための政府の取り組み
  • 今後の動向
    • 技術の進歩
  • 促進要因と抑制要因の影響

第6章 感染症体外診断薬市場：世界市場分析

  • 感染症体外診断薬市場の売上高、2021年～2031年
  • 感染症体外診断薬市場の予測分析

第7章 感染症体外診断薬市場分析-用途別

  • HIVまたはエイズ
  • 結核
  • B型およびC型肝炎
  • マラリア
  • その他

第8章 感染症体外診断薬市場分析-エンドユーザー別

  • 病院および診療所
  • 診断研究所
  • 血液バンク
  • その他

第9章 感染症体外診断薬市場分析-地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • アジア太平洋地域のその他諸国
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • その他中東とアフリカ
  • 中南米
    • ブラジル
    • アルゼンチン
    • その他中南米

第10章 競合情勢

  • 主要企業によるヒートマップ分析
  • 企業のポジショニングと集中度

第11章 業界情勢

  • 世界の感染症体外診断薬市場における成長戦略
  • 有機的成長戦略
  • 無機的成長戦略

第12章 企業プロファイル

  • ABBOTT LABORATORIES
  • F. HOFFMANN-LA ROCHE LTD
  • BECTON DICKINSON AND CO
  • SYSMEX CORP
  • BIOMERIEUX SA
  • BIO-RAD LABORATORIES INC
  • QIAGEN NV
  • QUIDELORTHO CORP
  • BRUKER CORP
  • DANAHER CORP

第13章 付録

図表

List Of Tables

  • Table 1. Infectious Disease In vitro Diagnostics Market Segmentation
  • Table 2. Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million)
  • Table 3. Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million)
  • Table 4. Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 5. Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 6. Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 7. Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 8. North America: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 9. North America: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 10. North America: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 11. North America: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 12. United States: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 13. United States: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 14. United States: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 15. United States: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 16. Canada: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 17. Canada: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 18. Canada: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 19. Canada: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 20. Mexico: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 21. Mexico: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 22. Mexico: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 23. Mexico: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 24. Europe: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 25. Europe: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 26. Europe: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 27. Europe: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 28. United Kingdom: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 29. United Kingdom: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 30. United Kingdom: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 31. United Kingdom: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 32. Germany: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 33. Germany: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 34. Germany: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 35. Germany: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 36. France: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 37. France: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 38. France: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 39. France: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 40. Italy: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 41. Italy: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 42. Italy: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 43. Italy: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 44. Spain: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 45. Spain: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 46. Spain: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 47. Spain: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 48. Rest of Europe: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 49. Rest of Europe: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 50. Rest of Europe: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 51. Rest of Europe: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 52. Asia Pacific: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 53. Asia Pacific: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 54. Asia Pacific: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 55. Asia Pacific: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 56. China: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 57. China: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 58. China: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 59. China: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 60. Japan: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 61. Japan: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 62. Japan: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 63. Japan: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 64. India: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 65. India: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 66. India: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 67. India: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 68. Australia: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 69. Australia: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 70. Australia: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 71. Australia: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 72. South Korea: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 73. South Korea: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 74. South Korea: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 75. South Korea: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 76. Rest of APAC: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 77. Rest of APAC: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 78. Rest of APAC: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 79. Rest of APAC: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 80. Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 81. Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 82. Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 83. Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 84. South Africa: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 85. South Africa: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 86. South Africa: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 87. South Africa: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 88. Saudi Arabia: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 89. Saudi Arabia: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 90. Saudi Arabia: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 91. Saudi Arabia: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 92. United Arab Emirates: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 93. United Arab Emirates: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 94. United Arab Emirates: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 95. United Arab Emirates: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 96. Rest of Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 97. Rest of Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 98. Rest of Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 99. Rest of Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 100. South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 101. South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 102. South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 103. South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 104. Brazil: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 105. Brazil: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 106. Brazil: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 107. Brazil: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 108. Argentina: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 109. Argentina: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 110. Argentina: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 111. Argentina: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 112. Rest of South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 113. Rest of South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 114. Rest of South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 115. Rest of South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 116. Heat Map Analysis by Key Players
  • Table 117. Recent Organic Growth Strategies in the global Infectious Disease In-Vitro Diagnostics Market
  • Table 118. Recent Inorganic Growth Strategies in the Global Infectious Disease In-Vitro Diagnostics Market
  • Table 119. Glossary of Terms, Infectious Disease In vitro Diagnostics Market

List Of Figures

  • Figure 1. Infectious Disease In vitro Diagnostics Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Infectious Disease In vitro Diagnostics Market Revenue (US$ Million), 2021-2031
  • Figure 5. Infectious Disease In vitro Diagnostics Market Share (%) - by Applications (2024 and 2031)
  • Figure 6. HIV or AIDS: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Tuberculosis: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Hepatitis B and C: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Malaria: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Others: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Infectious Disease In vitro Diagnostics Market Share (%) - by End User (2024 and 2031)
  • Figure 12. Hospitals and Clinics: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Diagnostic Laboratories: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Blood Bank: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Others: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Infectious Disease In vitro Diagnostics Market Breakdown by Region, 2024 and 2031 (%)
  • Figure 17. North America: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2031 (US$ Million)
  • Figure 18. North America: Infectious Disease In vitro Diagnostics Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 19. United States: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 20. Canada: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 21. Mexico: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 22. Europe: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2031 (US$ Million)
  • Figure 23. Europe: Infectious Disease In vitro Diagnostics Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 24. United Kingdom: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 25. Germany: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 26. France: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 27. Italy: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 28. Spain: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 29. Rest of Europe: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 30. Asia Pacific: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2031 (US$ Million)
  • Figure 31. Asia Pacific: Infectious Disease In vitro Diagnostics Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 32. China: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 33. Japan: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 34. India: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 35. Australia: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 36. South Korea: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 37. Rest of APAC: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 38. Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2031 (US$ Million)
  • Figure 39. Middle East and Africa: Infectious Disease In vitro Diagnostics Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 40. South Africa: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 41. Saudi Arabia: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 42. United Arab Emirates: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 43. Rest of Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 44. South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2031 (US$ Million)
  • Figure 45. South and Central America: Infectious Disease In vitro Diagnostics Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 46. Brazil: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 47. Argentina: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 48. Rest of South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 49. Company Positioning & Concentration
  • Figure 50. Growth Strategies in the Global Infectious Disease In-Vitro Diagnostics Market - Global Infectious Disease In vitro Diagnostics Market
目次
Product Code: TIPRE00040978

The infectious disease in vitro diagnostics market size is expected to grow from US$ 45.69 billion in 2024 to US$ 76.71 billion by 2031; it is projected to register a CAGR of 7.7% during 2025-2031. The increasing prevalence of infectious diseases and strategic developments by key players are noteworthy factors contributing to the expansion of the infectious disease in vitro diagnostics market size. However, the inadequate reimbursement scenario hinders the infectious disease in vitro diagnostics market growth.

Technological advancements involving the development and integration of molecular diagnostics and automation systems enhance the accuracy, speed, and accessibility of infectious disease detection. Below are a few instances:

In June 2024, MP Biomedicals introduced a new line of rapid immunochromatographic assays for Helicobacter pylori, Salmonella typhi, and Vibrio cholerae, intended for point-of-care in resource-constrained environments.

In June 2024, Roche gained FDA Emergency Use Authorization (EUA) for its cobas liat multiplex PCR panel updated to detect SARS-CoV-2, influenza A/B, and RSV simultaneously, advancing syndromic respiratory infection management in less than 20 minutes.

In July 2024, Sherlock Biosciences initiated clinical trials for its CRISPR-based over-the-counter (OTC) test for gonorrhea and chlamydia in May 2024, with an eye toward a 2025 launch. APEX-TB, integrating machine learning from AI and nanotechnology, was also launched to provide accurate, real-time molecular diagnostics using portable devices.

In June 2024, QIAGEN introduced 35 new wet-lab tested digital PCR Microbial DNA Detection Assays to its digital PCR (dPCR) platform QIAcuity, noticeably strengthening its capabilities in microbial research.

These advancements are part of a larger movement toward decentralized, user-centric, and fast diagnostic technologies guiding the future of infectious disease care. This is expected to contribute to the growth of the infectious disease in vitro diagnostics market in the coming years.

End User -Based Insights

Based on end user, the infectious disease in vitro diagnostics market is segmented into hospitals and clinics, diagnostics laboratories, blood bank, and others. The hospitals and clinics segment held the largest infectious disease in vitro diagnostics market share in 2024. The need for accurate, timely diagnosis in hospitals and clinics is rising steadily due to frequent outbreaks of Lassa fever, cholera, tuberculosis, and malaria. The soaring patient load and demand for quality care have pushed hospitals to adopt more sophisticated diagnostic tools, including molecular diagnostics. Increased government funding, donor support, and infrastructure improvements in secondary and tertiary hospitals further boost the adoption of IVD products. Integrating IVD in hospital protocols improves patient outcomes, reduces unnecessary antibiotic use, and ensures better management of infectious diseases in urban and rural health centers, thereby fueling the infectious disease in vitro diagnostics market growth.

The World Health Organization and Mexico's Ministry of Health's National Institute of Respiratory Diseases are among the primary and secondary sources referred to while preparing the infectious disease in vitro diagnostics market report.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Analyst Market Outlook

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:
  • 3.3 Assumptions and Limitations

4. Infectious Disease In vitro Diagnostics Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Infectious Disease In vitro Diagnostics Market - Key Market Dynamics

  • 5.1 Infectious Disease In vitro Diagnostics Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Increasing Prevalence of Infectious Diseases
    • 5.2.2 Strategic Developments by Key Players
  • 5.3 Market Restraints
    • 5.3.1 Inadequate Reimbursement Scenario
  • 5.4 Market Opportunities
    • 5.4.1 Government Initiatives to Increase Awareness Regarding Infectious Diseases
  • 5.5 Future Trends
    • 5.5.1 Technological Advancements
  • 5.6 Impact of Drivers and Restraints:

6. Infectious Disease In vitro Diagnostics Market - Global Market Analysis

  • 6.1 Infectious Disease In vitro Diagnostics Market Revenue (US$ Million), 2021-2031
  • 6.2 Infectious Disease In vitro Diagnostics Market Forecast Analysis

7. Infectious Disease In vitro Diagnostics Market Analysis - by Applications

  • 7.1 HIV or AIDS
    • 7.1.1 Overview
    • 7.1.2 HIV or AIDS: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Tuberculosis
    • 7.2.1 Overview
    • 7.2.2 Tuberculosis: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Hepatitis B and C
    • 7.3.1 Overview
    • 7.3.2 Hepatitis B and C: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Malaria
    • 7.4.1 Overview
    • 7.4.2 Malaria: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)

8. Infectious Disease In vitro Diagnostics Market Analysis - by End User

  • 8.1 Hospitals and Clinics
    • 8.1.1 Overview
    • 8.1.2 Hospitals and Clinics: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Diagnostic Laboratories
    • 8.2.1 Overview
    • 8.2.2 Diagnostic Laboratories: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Blood Bank
    • 8.3.1 Overview
    • 8.3.2 Blood Bank: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Others
    • 8.4.1 Overview
    • 8.4.2 Others: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)

9. Infectious Disease In vitro Diagnostics Market - Geographical Analysis

  • 9.1 Overview
  • 9.2 North America
    • 9.2.1 North America Infectious Disease In vitro Diagnostics Market Overview
    • 9.2.2 North America: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2031 (US$ Million)
      • 9.2.2.1 North America: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by Applications
      • 9.2.2.2 North America: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by End User
    • 9.2.3 North America: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by Country
      • 9.2.3.1 United States: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.2.3.1.1 United States: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
        • 9.2.3.1.2 United States: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
      • 9.2.3.2 Canada: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.2.3.2.1 Canada: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
        • 9.2.3.2.2 Canada: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
      • 9.2.3.3 Mexico: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.2.3.3.1 Mexico: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
        • 9.2.3.3.2 Mexico: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
  • 9.3 Europe
    • 9.3.1 Europe Infectious Disease In vitro Diagnostics Market Overview
    • 9.3.2 Europe: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2031 (US$ Million)
      • 9.3.2.1 Europe: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by Applications
      • 9.3.2.2 Europe: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by End User
    • 9.3.3 Europe: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by Country
      • 9.3.3.1 United Kingdom: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.3.3.1.1 United Kingdom: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
        • 9.3.3.1.2 United Kingdom: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
      • 9.3.3.2 Germany: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.3.3.2.1 Germany: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
        • 9.3.3.2.2 Germany: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
      • 9.3.3.3 France: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.3.3.3.1 France: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
        • 9.3.3.3.2 France: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
      • 9.3.3.4 Italy: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.3.3.4.1 Italy: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
        • 9.3.3.4.2 Italy: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
      • 9.3.3.5 Spain: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.3.3.5.1 Spain: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
        • 9.3.3.5.2 Spain: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
      • 9.3.3.6 Rest of Europe: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.3.3.6.1 Rest of Europe: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
        • 9.3.3.6.2 Rest of Europe: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
  • 9.4 Asia Pacific
    • 9.4.1 Asia Pacific Infectious Disease In vitro Diagnostics Market Overview
    • 9.4.2 Asia Pacific: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2031 (US$ Million)
      • 9.4.2.1 Asia Pacific: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by Applications
      • 9.4.2.2 Asia Pacific: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by End User
    • 9.4.3 Asia Pacific: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by Country
      • 9.4.3.1 China: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.4.3.1.1 China: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
        • 9.4.3.1.2 China: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
      • 9.4.3.2 Japan: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.4.3.2.1 Japan: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
        • 9.4.3.2.2 Japan: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
      • 9.4.3.3 India: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.4.3.3.1 India: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
        • 9.4.3.3.2 India: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
      • 9.4.3.4 Australia: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.4.3.4.1 Australia: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
        • 9.4.3.4.2 Australia: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
      • 9.4.3.5 South Korea: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.4.3.5.1 South Korea: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
        • 9.4.3.5.2 South Korea: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
      • 9.4.3.6 Rest of APAC: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.4.3.6.1 Rest of APAC: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
        • 9.4.3.6.2 Rest of APAC: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
  • 9.5 Middle East and Africa
    • 9.5.1 Middle East and Africa Infectious Disease In vitro Diagnostics Market Overview
    • 9.5.2 Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2031 (US$ Million)
      • 9.5.2.1 Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by Applications
      • 9.5.2.2 Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by End User
    • 9.5.3 Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by Country
      • 9.5.3.1 South Africa: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.5.3.1.1 South Africa: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
        • 9.5.3.1.2 South Africa: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
      • 9.5.3.2 Saudi Arabia: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.5.3.2.1 Saudi Arabia: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
        • 9.5.3.2.2 Saudi Arabia: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
      • 9.5.3.3 United Arab Emirates: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.5.3.3.1 United Arab Emirates: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
        • 9.5.3.3.2 United Arab Emirates: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
      • 9.5.3.4 Rest of Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.5.3.4.1 Rest of Middle East and Africa: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
        • 9.5.3.4.2 Rest of Middle East and Africa: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
  • 9.6 South and Central America
    • 9.6.1 South and Central America Infectious Disease In vitro Diagnostics Market Overview
    • 9.6.2 South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2031 (US$ Million)
      • 9.6.2.1 South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by Applications
      • 9.6.2.2 South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by End User
    • 9.6.3 South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by Country
      • 9.6.3.1 Brazil: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.6.3.1.1 Brazil: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
        • 9.6.3.1.2 Brazil: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
      • 9.6.3.2 Argentina: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.6.3.2.1 Argentina: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
        • 9.6.3.2.2 Argentina: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
      • 9.6.3.3 Rest of South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.6.3.3.1 Rest of South and Central America: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
        • 9.6.3.3.2 Rest of South and Central America: Infectious Disease In vitro Diagnostics Market Breakdown, by End User

10. Competitive Landscape

  • 10.1 Heat Map Analysis by Key Players
  • 10.2 Company Positioning & Concentration

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Global Infectious Disease In-Vitro Diagnostics Market
  • 11.3 Organic Growth Strategies
    • 112.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 112.4.1 Overview

12. Company Profiles

  • 12.1. ABBOTT LABORATORIES
    • 12.1.1. Key Facts
    • 12.1.2. Business Description
    • 12.1.3. Products and Services
    • 12.1.4. Financial Overview
    • 12.1.5. SWOT Analysis
    • 12.1.6. Key Developments
  • 12.2. F. HOFFMANN-LA ROCHE LTD
    • 12.2.1. Key Facts
    • 12.2.2. Business Description
    • 12.2.3. Products and Services
    • 12.2.4. Financial Overview
    • 12.2.5. SWOT Analysis
    • 12.2.6. Key Developments
  • 12.3. BECTON DICKINSON AND CO
    • 12.3.1. Key Facts
    • 12.3.2. Business Description
    • 12.3.3. Products and Services
    • 12.3.4. Financial Overview
    • 12.3.5. SWOT Analysis
    • 12.3.6. Key Developments
  • 12.4. SYSMEX CORP
    • 12.4.1. Key Facts
    • 12.4.2. Business Description
    • 12.4.3. Products and Services
    • 12.4.4. Financial Overview
    • 12.4.5. SWOT Analysis
  • 12.5. BIOMERIEUX SA
    • 12.5.1. Key Facts
    • 12.5.2. Business Description
    • 12.5.3. Products and Services
    • 12.5.4. Financial Overview
    • 12.5.5. SWOT Analysis
    • 12.5.6. Key Developments
  • 12.6. BIO-RAD LABORATORIES INC
    • 12.6.1. Key Facts
    • 12.6.2. Business Description
    • 12.6.3. Products and Services
    • 12.6.4. Financial Overview
    • 12.6.5. SWOT Analysis
    • 12.6.6. Key Developments
  • 12.6. QIAGEN NV
    • 12.6.1. Key Facts
    • 12.6.2. Business Description
    • 12.6.3. Products and Services
    • 12.6.4. Financial Overview
    • 12.6.5. SWOT Analysis
    • 12.6.6. Key Developments
  • 12.8. QUIDELORTHO CORP
    • 12.8.1. Key Facts
    • 12.8.2. Business Description
    • 12.8.3. Products and Services
    • 12.8.4. Financial Overview
    • 12.8.5. SWOT Analysis
    • 12.8.6. Key Developments
  • 12.9. BRUKER CORP
    • 12.9.1. Key Facts
    • 12.9.2. Business Description
    • 12.9.3. Products and Services
    • 12.9.4. Financial Overview
    • 12.9.5. SWOT Analysis
    • 12.9.6. Key Developments
  • 12.10. DANAHER CORP
    • 12.10.1. Key Facts
    • 12.10.2. Business Description
    • 12.10.3. Products and Services
    • 12.10.4. Financial Overview
    • 12.10.5. SWOT Analysis
    • 12.10.6. Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms